Skip to main content
Equibles

UBS Group AG

Position in CLDI — Calidi Biotherapeutics, Inc.

CIK 1610520 ZURICH, V8
Back to CLDI Full portfolio

Position in CLDI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,339
-$7,451 QoQ
Shares Held
493
+4.9% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 23 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CLDI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,672,124 across 561 Biotechnology names. CLDI ranks #505 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in CLDI

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,339 7,882
2025-12-31 $8,790 7,514
2025-09-30 $3,896 2,564
2025-06-30 $10,327 44,902
2025-03-31 $1 1
2024-12-31 $10,118 8,799
2024-09-30 $1,050 922
2024-06-30 $1 10
2024-03-31 $5 10
2023-12-31 $15 10
2023-09-30 $33 10
2023-06-30 $104 10
2023-03-31 $112 11
2022-12-31 $243 24
2022-06-30 $15,784 1,588
2022-03-31 $15,299 1,547
2021-12-31 $72,741 7,415